Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5945 record(s)

Req # A-2023-001151

Adverse Drug Reaction (ADR). Report number: 001059970.

Organization: Health Canada

3 page(s)
February 2024

Req # A-2023-001173

Adverse Drug Reaction (ADR). Report number: E2B_02997619.

Organization: Health Canada

34 page(s)
February 2024

Req # A-2023-001204

Adverse Drug Reaction (ADR). Report number: E2B_06648474.

Organization: Health Canada

14 page(s)
February 2024

Req # A-2023-001234

Adverse Drug Reaction (ADR). Report number: E2B_06709011.

Organization: Health Canada

9 page(s)
February 2024

Req # A-2023-001268

Adverse Drug Reactions (ADRs). Report numbers: 001065721, 001065757, 001070834, 001073005.

Organization: Health Canada

26 page(s)
February 2024

Req # A-2023-001340

Adverse Drug Reactions (ADRs) for Atorvastatin-10. Report numbers: 000961592, 000989963, 001066344, 001068222. ADRs for Atorvastatin-20. Report numbers: 000732131, 000938663. ADRs for Atorvastatin-40. Report numbers: 000930000, E2B_02357512. ADR for Atorvastatin-80. Report number: E2B_02176818.

Organization: Health Canada

33 page(s)
February 2024

Req # A-2023-001345

Adverse Drug Reaction (ADR). Report number: 001070471.

Organization: Health Canada

2 page(s)
February 2024

Req # A-2023-001360

Adverse Drug Reaction (ADR) for Midazolam. Report number: 001066753.

Organization: Health Canada

13 page(s)
February 2024

Req # A-2023-001363

Adverse Drug Reaction (ADR). Report number: 001051697.

Organization: Health Canada

7 page(s)
February 2024

Req # A-2015-000032

Documentation, forms, and paperwork relating to On-Site Evaluations done at Alexion Pharmaceuticals between December 3 - December 5 2008, Hoffman-La Roche between November 15 - November 20 2004, and Amgen Canada between February 12 - February 16 2007. Documentation, forms, and paperwork relating to Good Manufactoring Practice (GMP) inspections performed at Alexion Pharmaceuticals at October 29, 2013, Hoffman-La Roche at January 14th, 2013, and Amgen Canada at January 9th 2012.

Organization: Health Canada

301 page(s)
February 2024
Date modified: